Condition
Ivonescimab clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Ivonescimab clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Ivonescimab with albumin‑paclitaxel and cisplatin before surgery for esophageal squamous cell carcinoma
This trial tests whether adding ivonescimab to albumin‑paclitaxel and cisplatin before surgery helps people with resectable, locally advanced esophageal squamous cell carcinoma.
-
Ivonescimab for previously treated advanced clear cell kidney cancer
This tests whether ivonescimab can shrink or control advanced clear cell kidney cancer in people whose disease progressed after at least one prior systemic treatment.
Related topics
Quick answers
How many Ivonescimab clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.